This is normal for the FDA. Generex just needs to to show it does what the team has strongly stated, with as much haste as possible.

Don't blame the FDA. It is Generex's responsibility as the trial sponsor to move this forward.

GNBT may have an option for authorization as a booster.

I'm not going to participate in big pharma/FDA conspiracy discussions. Nothing to be gained that I can see. If is nice to have someone to blame.